-transparent.png){kind=logo}
Previous studies suggested that the potent immunosuppressive activities of transforming growth factor-beta (TGF-beta) were mediated in part through the inhibition of IL-2-dependent S-phase progression and mitosis of activated T cells. To further investigate the mechanism of T cell growth inhibition by TGF-beta, two constitutively activated murine T cell clones were employed as defined model systems for the growth factor-dependent phase of T cell proliferation. The Th cell line, HT-2, proliferated in response to either IL-2 or IL-4, whereas the cytotoxic T cell line, CT6, exhibited strict dependence on IL-2 for growth stimulation. In both cell lines, picomolar concentrations of TGF-beta inhibited S-phase progression stimulated by IL-2 or IL-4. TGF-beta pretreatment decreased the expression of high affinity IL-2R on HT-2 cells, but not on CT6 cells. In contrast, IL-2-stimulated transferrin receptor expression was markedly inhibited by TGF-beta in both T cell lines. Analyses of growth factor-dependent specific mRNA accumulation revealed that TGF-beta exerted selective inhibitory effects on gene expression in HT-2 and CT6 cells. TGF-beta significantly reduced early (1 to 2 h) increases in c-myc mRNA levels stimulated by IL-2 or IL-4 in both cell lines. In HT-2 cells, TGF-beta pretreatment also inhibited the early increase in granulocyte-macrophage CSF mRNA stimulated by IL-2 or IL-4. The inhibition of c-myc and granulocyte-macrophage cyte-macrophage CSF gene expression by TGF-beta was explained, at least in part, by suppression of the growth factor-dependent transcriptional activation of these genes. These studies suggest that inhibition of c-myc gene transcription may play a fundamental role in the antiproliferative effect of TGF-beta on IL-2- or IL-4-stimulated T cells.
J J Ruegemer, and
S N Ho, and
J A Augustine, and
J W Schlager, and
M P Bell, and
D J McKean, and
R T Abraham
January 1996,
Immunological investigations,
J J Ruegemer, and
S N Ho, and
J A Augustine, and
J W Schlager, and
M P Bell, and
D J McKean, and
R T Abraham
October 1989,
Journal of cellular physiology,
J J Ruegemer, and
S N Ho, and
J A Augustine, and
J W Schlager, and
M P Bell, and
D J McKean, and
R T Abraham
October 2007,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J J Ruegemer, and
S N Ho, and
J A Augustine, and
J W Schlager, and
M P Bell, and
D J McKean, and
R T Abraham
January 1995,
Archives of dermatological research,
J J Ruegemer, and
S N Ho, and
J A Augustine, and
J W Schlager, and
M P Bell, and
D J McKean, and
R T Abraham
April 1995,
Cancer research,
J J Ruegemer, and
S N Ho, and
J A Augustine, and
J W Schlager, and
M P Bell, and
D J McKean, and
R T Abraham
July 2007,
Proceedings of the American Thoracic Society,
J J Ruegemer, and
S N Ho, and
J A Augustine, and
J W Schlager, and
M P Bell, and
D J McKean, and
R T Abraham
September 2006,
Immunity,
J J Ruegemer, and
S N Ho, and
J A Augustine, and
J W Schlager, and
M P Bell, and
D J McKean, and
R T Abraham
May 2013,
Immunology,
J J Ruegemer, and
S N Ho, and
J A Augustine, and
J W Schlager, and
M P Bell, and
D J McKean, and
R T Abraham
January 1992,
Growth factors (Chur, Switzerland),
J J Ruegemer, and
S N Ho, and
J A Augustine, and
J W Schlager, and
M P Bell, and
D J McKean, and
R T Abraham
January 2000,
Journal of immunology (Baltimore, Md. : 1950),
